INO
INO
NASDAQ · Biotechnology

Inovio Pharmaceuticals Inc

$1.61
+0.06 (+3.87%)
As of Mar 29, 10:41 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +1,118.0% upside
Low Target $14.26
Average Target $19.61
High Target $29.32
Current Price $1.61
Current
$1.61
Target
$19.61
$14.26 $19.61 avg $29.32
Scenario Analysis
Bear Case
$14.26
785.7%
Low target
Base Case
$19.61
+1,118.0%
Avg target
Bull Case
$29.32
+1,721.1%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$2.98
-46.0% from high
52-Week Low
$1.30
+23.8% from low
Target vs 52W High
$19.61
+558.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%